How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Business Services · Forecast 2027–2033
CCD (Cyclic Cluster Dextrin) Market
- By Application: Sports Nutrition, Functional Foods and Beverages, Pharmaceuticals, Animal Nutrition, Cosmetics
- By Form: Powder, Liquid, Granules
- By End-User: Athletes, Bodybuilders, General Consumers, Healthcare Providers
- By Distribution Channel: Online Retail, Specialty Stores, Pharmacies, Direct Sales, Supermarkets/Hypermarkets
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Sports Nutrition leads By Application at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 13 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
11 chapters · 270 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.63 →
- 10 Competitive Landscape 5 sections p.165 →
- 11 Company Profiles 13 players: SWOT & benchmarking p.173 →
Full report · locked preview
Everything inside the CCD (Cyclic Cluster Dextrin) Market report
A complete, evidence-based study - 11 chapters and 113 sections covering market size, segmentation across 4 axes, regional analysis and 13 company profiles, forecast to 2033.
Segmentation covered
Application 5
Form 3
End-User 4
Distribution Channel 5
Companies profiled
Ingredion Incorporated
Tate & Lyle PLC
Roquette Frères
Cargill
Incorporated
ADM (Archer Daniels Midland Company)
Matsutani Chemical Industry Co. Ltd.
Wacker Chemie AG
Tereos S.A.
BENEO GmbH
MGP Ingredients Inc.
Meihua Holdings Group Co. Ltd.
+1 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
13 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Ingredion Incorporated
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Tate & Lyle PLC
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Roquette Frères
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Cargill
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Incorporated
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →ADM (Archer Daniels Midland Company)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.184 →Matsutani Chemical Industry Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Wacker Chemie AG
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Tereos S.A.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →BENEO GmbH
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →MGP Ingredients Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.214 →Meihua Holdings Group Co. Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.220 →Jungbunzlauer Suisse AG
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$3,136M by 2033 · 7.9% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Sports Nutrition43.8
- Functional Foods and Beverages17.9
- Pharmaceuticals7.7
- Animal Nutrition13.5
- Cosmetics17.0
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$562.4M → $974.3M · 7.1%
Europe$392.0M → $806.5M · 9.4%
Asia Pacific$357.9M → $599.8M · 6.7%
Latin America$221.6M → $390.8M · 7.4%
Middle East and Africa$170.4M → $280.5M · 6.4%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →7.872026
7.892027
7.892028
7.922029
7.922030
7.922031
7.952032
7.952033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Ingredion Incorporated18.8
- Tate & Lyle PLC22.1
- Roquette Frères9.6
- Cargill10.3
- Incorporated5.4
- ADM (Archer Daniels Midland Company)5.8
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Application20.3%
Form31.7%
End-User13.6%
Distribution Channel34.5%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America31.9
- Europe26.4
- Asia Pacific19.7
- Latin America12.8
- Middle East and Africa9.2
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Ingredion Incorporated | 93 | 98 | 83 | 86 | 84 | 93 | 90 |
| Tate & Lyle PLC | 86 | 92 | 78 | 80 | 73 | 80 | 82 |
| Roquette Frères | 75 | 82 | 62 | 68 | 68 | 69 | 71 |
| Cargill | 75 | 72 | 76 | 82 | 61 | 81 | 75 |
| Incorporated | 62 | 56 | 62 | 69 | 52 | 58 | 60 |
| ADM (Archer Daniels Midland Company) | 54 | 60 | 55 | 61 | 71 | 51 | 59 |
| Matsutani Chemical Industry Co. Ltd. | 47 | 52 | 41 | 43 | 52 | 59 | 49 |
| Wacker Chemie AG | 54 | 36 | 36 | 37 | 42 | 57 | 44 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Ingredion Incorporated
- Tate & Lyle PLC
- Roquette Frères
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Ingredion Incorporated | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Tate & Lyle PLC | ✓ | ✓ | ◐ | ✓ | ✓ | ✓ |
| Roquette Frères | ✓ | ✓ | ◐ | − | ◐ | ◐ |
| Cargill | ✓ | ◐ | ◐ | ◐ | ◐ | ✓ |
| Incorporated | ◐ | ◐ | ✓ | ◐ | ◐ | ◐ |
| ADM (Archer Daniels Midland Company) | ◐ | ◐ | − | ◐ | ◐ | − |
| Matsutani Chemical Industry Co. Ltd. | − | − | − | − | ◐ | − |
| Wacker Chemie AG | ◐ | − | − | − | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Ingredion Incorporated90
2Tate & Lyle PLC82
3Cargill75
4Roquette Frères71
5Incorporated60
6ADM (Archer Daniels Midland Company)59
7Matsutani Chemical Industry Co. Ltd.49
8Wacker Chemie AG44
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Ingredion IncorporatedTate & Lyle PLC
Challenger2
Strong scale, closing on the leaders.
Roquette FrèresCargill
Contender2
Focused players with pockets of strength.
IncorporatedADM (Archer Daniels Midland Company)
Niche2
Specialists in a single segment or region.
Matsutani Chemical Industry Co. Ltd.Wacker Chemie AG
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Application in North America, then scale across CCD (Cyclic Cluster Dextrin) Market — a $253M beachhead inside a $3.81B market.
Beachhead (SOM)$253Mobtainable near-term
Serviceable (SAM)$1.56Breachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale5 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion88 fit
Sports Nutrition
Best fit — highest urgency & budget in Application.
Economic buyer79 fit
Functional Foods and Beverages
Strong fit — clear ROI and a fast path to value.
End user64 fit
Pharmaceuticals
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Application in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Form & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + End-User
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales43%
Partner / channel29%
Digital / self-serve23%
Marketplaces6%
Positioning & messaging
§GTM 2 · p.194 →For Application leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win CCD (Cyclic Cluster Dextrin) Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified45%
Sales qualified25%
Evaluation14%
Closed-won5%
$12.8KCAC
$65KLTV
5.0:1LTV : CAC
< 3 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
CCD (Cyclic Cluster Dextrin) Market is a durable-growth opportunity — $4.87B by 2033, compounding at 6.0%.
TAM · 2025$3.05Btoday
TAM · 2033$4.87Bforecast
CAGR6.0%2027–2033
Cumulative$35.1Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$4.87BTotal addressable market
SAM$1.90BServiceable available market
SOM$357MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →6.0% CAGR
Demand compounds through 2033, outpacing GDP across Application.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Application moving from early to mainstream — durable secular demand.
Consolidation upside
13+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$4.87BLarge & growingTAM by 2033 at 6.0% CAGR
$1.90BServiceable nowreachable with today’s model
$357MBeachhead winobtainable near-term share
13+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$3.80BBear3.9% CAGR
$4.87BBase6.0% CAGR
$6.23BBull7.9% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Form optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
CCD (Cyclic Cluster Dextrin) Market — a $5.48B market by 2033. Plan: grow share from 5.9% to 11.1%.
Market size · 2033$5.48Btotal addressable
Market CAGR3.5%2027–2033
Target share11.1%from 5.9% today
Revenue ambition$608Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 5.9% | 11.1% | On track |
| Revenue | $349M | $608M | Ahead |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 2 of 4 axes | 4 of 4 axes | Ahead |
| Gross margin | 34.7% | 46.0% | At risk |
| Customer retention | 90.8% | 92.4% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Application
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Form capability
A defensible second engine — invest in Form to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Application share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Form
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $85M capacity & capability investment
- Greenlight bolt-on M&A in Form
- Authorise North America expansion plan
- Fund R&D program for Application leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownOn track
- Competitive share lossBehind
- Input-cost & supply riskAhead
- Regulatory / policy changeAt risk
- Execution & talentOn track
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the CCD (Cyclic Cluster Dextrin) Market conversation — a $7.45B market you can size, segment and defend in minutes.
Market size · 2033$7.45Btotal opportunity
Growth5.7%CAGR to 2033
Addressable buyers1,025+accounts in scope
Typical ROI6.5×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Application
Goal Grow share in Application
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →6.5×return on cost, year one
< 4 mopayback period
$58K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
13+players profiled in this market
Coverage includes
Ingredion IncorporatedTate & Lyle PLCRoquette FrèresCargillIncorporatedADM (Archer Daniels Midland Company)Matsutani Chemical Industry Co. Ltd.Wacker Chemie AG+5 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your CCD (Cyclic Cluster Dextrin) Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
CCD (Cyclic Cluster Dextrin) Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Business Services · scroll →CCD Ballistic Camera Market
Market size, share, segmentation and regional forecast.
$5.4B market · 2025 base year
View reportCcd Cameras Market
Market size, share, segmentation and regional forecast.
$5.6B market · 2025 base year
View reportCCD Color Spectroradiometer Market
Market size, share, segmentation and regional forecast.
$600M market · 2025 base year
View reportCcd Detectors Market
Market size, share, segmentation and regional forecast.
$4.2B market · 2025 base year
View reportCcd Image Sensor Market
Market size, share, segmentation and regional forecast.
$2.6B market · 2025 base year
View reportCCD Laser Displacement Sensor Market
Market size, share, segmentation and regional forecast.
$1.7B market · 2025 base year
View reportCCD Machine Vision System Market
Market size, share, segmentation and regional forecast.
$5.7B market · 2025 base year
View reportCCD Photodetector Market
Market size, share, segmentation and regional forecast.
$5.3B market · 2025 base year
View reportCCD Registering Screen Printer Market
Market size, share, segmentation and regional forecast.
$303M market · 2025 base year
View reportCC-Link Cable Market
Market size, share, segmentation and regional forecast.
$2.5B market · 2025 base year
View reportCctv Accessories Market
Market size, share, segmentation and regional forecast.
$2.5B market · 2025 base year
View reportCCTV Cameras for Rail Market
Market size, share, segmentation and regional forecast.
$3.6B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.